First-In-Class Combination Therapy Of A Copper(Ii) Metallo-Phosphorus Dendrimer With Cytotoxic Agents

ONCOLOGY(2018)

Cited 13|Views5
No score
Abstract
The metallo-phosphorus dendrimer 1G3-Cu (generation 3 dendrimer bearing 48 conjugated copper(II) on its surface) has antiproliferative activity related to its capacity to activate Bax translocation. In the present study, we evaluate the activity of an association of 1G3-Cu with 5 cytotoxic agents used in chemotherapy having different modes of action. Data show no additive effect with camptothecin and cisplatin, additivity with paclitaxel and MG132, and synergy with doxorubicin. Results suggest that the multivalent Cu-conjugated dendrimer 1G3-Cu ( activator of Bax translocation) plays an important role in boosting the clinical impact of Bax accumulation stimulated by the proteasome inhibitor MG132, antimitotic taxanes, and the topo II inhibitor doxorubicin. (C) 2018 S. Karger AG, Basel
More
Translated text
Key words
Combinations in oncology, Dendrimers, Camptothecin, Cisplatin, Paclitaxel, Doxorubicin, MG132
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined